Journal Watch · Proceedings of the National Academy of Sciences (PNAS) · 2026

A fully synthetic Golden Gate assembly system for engineering a <i>Pseudomonas aeruginosa</i> phiKMV-like phage.

This system demonstrates the potential of HC-GGA for the rapid production and engineering of phages and provides a chassis for the development of phages that broadly target the opportunistic human pathogen <i>P. aeruginosa</i>.

Sikkema AP, Kortright KE, Selvakumar H et al.Proceedings of the National Academy of Sciences (PNAS)3 min readPharma relevance 50/100

DOI: 10.1073/pnas.2525963123PMID: 41576076Study type: research study

TL;DR

This system demonstrates the potential of HC-GGA for the rapid production and engineering of phages and provides a chassis for the development of phages that broadly target the opportunistic human pathogen <i>P. aeruginosa</i>.

Key findings

  • These fragments are readily assembled in a high accuracy, one-pot reaction; phages can be rescued by direct transformation into <i>P. aeruginosa</i> PAO1 or <i>E. coli</i> 10-beta cells.
  • We demonstrate the precise generation of point mutations, DNA insertions, deletions, and the addition of fluorescence reporter genes that are expressed during phage replication.
  • All viable genotypes could be generated with near 100% success rate with minimal screening.
  • This system demonstrates the potential of HC-GGA for the rapid production and engineering of phages and provides a chassis for the development of phages that broadly target the opportunistic human pathogen <i>P. aeruginosa</i>.

Numbers at a glance (from the abstract)

100%

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

To overcome limitations of narrow host range inherent to many native phages, a robust genomic engineering platform is required which permits rapid and dependable genome production and engineering for nonmodel phage. Here, we describe an engineering platform for a phiKMV-like <i>Pseudomonas aeruginosa</i> phage, 41S1 that builds on previous work in the rapid assembly of small genomes through one-pot, High Complexity Golden Gate assembly (HC-GGA). This system divides the 41S1 genome into DNA fragments small enough to be conveniently synthesized and to avoid toxicity during DNA propagation, with all but one maintained in <i>Escherichia coli</i>.

Full abstract (original)

Background: Bacteriophages have applications in biotechnology, including human and veterinary medicine, agriculture, food safety, and biosecurity. One example of resurging importance is phage therapy, the use of phages to treat antibiotic-resistant bacterial infections. Phage therapy currently requires screening of environmental phages against the infecting strains for each individual patient, a laborious process that limits the development of standardized treatments.

What they did: To overcome limitations of narrow host range inherent to many native phages, a robust genomic engineering platform is required which permits rapid and dependable genome production and engineering for nonmodel phage. Here, we describe an engineering platform for a phiKMV-like <i>Pseudomonas aeruginosa</i> phage, 41S1 that builds on previous work in the rapid assembly of small genomes through one-pot, High Complexity Golden Gate assembly (HC-GGA). This system divides the 41S1 genome into DNA fragments small enough to be conveniently synthesized and to avoid toxicity during DNA propagation, with all but one maintained in <i>Escherichia coli</i>.

Results & conclusions: These fragments are readily assembled in a high accuracy, one-pot reaction; phages can be rescued by direct transformation into <i>P. aeruginosa</i> PAO1 or <i>E. coli</i> 10-beta cells. We demonstrate the precise generation of point mutations, DNA insertions, deletions, and the addition of fluorescence reporter genes that are expressed during phage replication. All viable genotypes could be generated with near 100% success rate with minimal screening. This system demonstrates the potential of HC-GGA for the rapid production and engineering of phages and provides a chassis for the development of phages that broadly target the opportunistic human pathogen <i>P. aeruginosa</i>.

Abstract © the authors / Proceedings of the National Academy of Sciences (PNAS) (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1073/pnas.2525963123 · PubMed 41576076.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Proceedings of the National Academy of Sciences (PNAS) for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.

Frequently asked questions

What did this Proceedings of the National Academy of Sciences (PNAS) study find?

This system demonstrates the potential of HC-GGA for the rapid production and engineering of phages and provides a chassis for the development of phages that broadly target the opportunistic human pathogen <i>P. aeruginosa</i>.

What type of study is this?

It is a research study, published in Proceedings of the National Academy of Sciences (PNAS) in 2026. To overcome limitations of narrow host range inherent to many native phages, a robust genomic engineering platform is required which permits rapid and dependable genome production and engineering for nonmodel phage.

Where can I read the original paper?

The original is at the publisher via DOI 10.1073/pnas.2525963123. PubMed ID: 41576076. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Sikkema AP, Kortright KE, Selvakumar H et al.. A fully synthetic Golden Gate assembly system for engineering a &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; phiKMV-like phage.. Proceedings of the National Academy of Sciences (PNAS) (2026). DOI: 10.1073/pnas.2525963123.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/a-fully-synthetic-golden-gate-assembly-system-for-engineering-a-lt-i-gt-963123/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides